Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Could molecular variations be predictive in right and left colon cancer in different gender and age groups?

PloS oneยท2026
Same author

Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy.

Frontiers in immunologyยท2026
Same author

Blood plasma and oral rinse liquid profiling for human papillomavirus in head and neck cancer - Unmasking false-positive p16 tissue cases and tracking disease dynamics.

Journal of translational medicineยท2026
Same author

Much ado about nothing: modeling amino acid replacement with predicted protein structures.

Bioinformatics (Oxford, England)ยท2026
Same author

DDR2-COL11A1 Transcriptional Coupling as a Candidate Therapeutic Target in Colorectal Cancer: Integrative Transcriptomic and Deep Learning Validation.

International journal of molecular sciencesยท2026
Same author

Robotic mini- or less open sublay for anterior abdominal wall hernia repair using the da Vinci single port robotic platform (SP MILOS): a preclinical feasibility study.

Hernia : the journal of hernias and abdominal wall surgeryยท2026

Related Experiment Video

Updated: May 15, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Network information improves cancer outcome prediction.

Janine Roy, Christof Winter, Zerrin Isik

    Briefings in Bioinformatics
    |December 21, 2012
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces NetRank, a network-based method that significantly improves cancer outcome prediction by identifying reliable gene biomarkers. It outperforms traditional methods, offering a more personalized approach to cancer treatment.

    Keywords:
    PageRankcancer biomarkergene expressionnetwork-basedoutcome prediction

    Related Experiment Videos

    Last Updated: May 15, 2026

    Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
    07:13

    Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

    Published on: April 18, 2025

    Area of Science:

    • Bioinformatics
    • Computational Biology
    • Cancer Research

    Background:

    • Cancer progression and patient outcomes vary significantly, yet treatments are often standardized.
    • Personalized medicine requires accurate prediction of disease progression from gene expression data.
    • Existing methods for gene signature identification face challenges with random gene selection and noisy data.

    Purpose of the Study:

    • To evaluate network-based methods, specifically NetRank, for identifying gene signatures in cancer outcome prediction.
    • To compare the performance of NetRank against classical statistical methods using a benchmark dataset collection.
    • To assess the consistency and reliability of network-derived gene signatures across different cancer types.

    Main Methods:

    • Developed a benchmark dataset collection of 25 cancer outcome prediction datasets.
    • Applied NetRank, a PageRank derivative utilizing protein-protein interaction networks, for gene signature identification.
    • Compared NetRank performance with classical methods like fold change and t-test.

    Main Results:

    • NetRank demonstrated significantly superior performance compared to classical methods.
    • Both regulatory and protein-protein interaction networks yielded comparable results, irrespective of network size.
    • Network-based methodology identified highly consistent gene signatures across diverse cancer types, unlike classical methods.

    Conclusions:

    • Network integration into gene expression analysis enhances biomarker identification reliability and accuracy.
    • NetRank provides a robust approach for personalized cancer treatment strategies.
    • This methodology deepens the understanding of cancer development and progression mechanisms.